news
Researchers have found that using GRL-0617, an PLpro inhibitor, in…
30 July 2020 | By Victoria Rees (Drug Target Review)
Researchers have found that using GRL-0617, an PLpro inhibitor, in cell cultures blocked SARS-CoV-2 production and supported the cell immune response.